[
  {
    "name": "ramipril",
    "tags": ["cardio", "renal", "safety"],
    "anchors": [
      {
        "id": "class",
        "title": "Drug class",
        "prompt": "Which class does ramipril belong to?",
        "type": "single",
        "options": [
          { "id": "ace", "label": "ACE inhibitor" },
          { "id": "arb", "label": "Angiotensin II receptor blocker (ARB)" },
          { "id": "ccb", "label": "Dihydropyridine calcium-channel blocker" },
          { "id": "bb", "label": "Beta-blocker" }
        ],
        "correct": ["ace"],
        "explanation": "Ramipril is an ACE inhibitor (prodrug → ramiprilat)."
      },
      {
        "id": "indications",
        "title": "Common indications",
        "prompt": "Select ALL common indications.",
        "type": "multi",
        "options": [
          { "id": "htn", "label": "Hypertension" },
          { "id": "hfrEF", "label": "Heart failure with reduced EF" },
          { "id": "postmi", "label": "Post-MI / secondary prevention" },
          { "id": "ckd", "label": "CKD with albuminuria (incl. diabetic nephropathy)" },
          { "id": "angina", "label": "Stable angina" }
        ],
        "correct": ["htn", "hfrEF", "postmi", "ckd"],
        "explanation": "HTN, HFrEF, post-MI, CKD with albuminuria are standard indications."
      },
      {
        "id": "moa",
        "title": "Mechanism of action",
        "prompt": "Which statement best describes the mechanism?",
        "type": "single",
        "options": [
          { "id": "moa_true", "label": "Inhibits ACE → ↓Ang II & ↓aldosterone + ↑bradykinin → vasodilation" },
          { "id": "moa_arb", "label": "Blocks AT1 receptor (ARB)" },
          { "id": "moa_ccb", "label": "Blocks L-type Ca²⁺ channels" }
        ],
        "correct": ["moa_true"],
        "explanation": "ACE inhibition lowers Ang II/aldosterone; bradykinin rises."
      },
      {
        "id": "adrs",
        "title": "Important adverse reactions",
        "prompt": "Select ALL clinically important ADRs.",
        "type": "multi",
        "options": [
          { "id": "cough", "label": "Dry cough" },
          { "id": "angio", "label": "Angioedema" },
          { "id": "k", "label": "Hyperkalaemia" },
          { "id": "hypo", "label": "Symptomatic hypotension" },
          { "id": "renal", "label": "Rise in creatinine/AKI risk" }
        ],
        "correct": ["cough", "angio", "k", "hypo", "renal"],
        "explanation": "Cough/angioedema (bradykinin), hyperkalaemia, hypotension, creatinine rise."
      },
      {
        "id": "interactions",
        "title": "Important drug–drug interactions",
        "prompt": "Select ALL interactions of concern.",
        "type": "multi",
        "options": [
          { "id": "kplus", "label": "K⁺ supplements / K-sparing diuretics (e.g., spironolactone)" },
          { "id": "nsaids", "label": "NSAIDs (esp. chronic)" },
          { "id": "lithium", "label": "Lithium" },
          { "id": "dualraas", "label": "Dual RAAS blockade (ARB/aliskiren)" }
        ],
        "correct": ["kplus", "nsaids", "lithium", "dualraas"],
        "explanation": "↑K⁺ risk; NSAIDs blunt effect & ↑AKI; lithium ↑; avoid dual RAAS."
      }
    ]
  },
  {
    "name": "atorvastatin",
    "tags": ["cardio"],
    "anchors": [
      {
        "id": "class",
        "title": "Drug class",
        "prompt": "Which class does atorvastatin belong to?",
        "type": "single",
        "options": [
          { "id": "statin", "label": "HMG-CoA reductase inhibitor (statin)" },
          { "id": "ezet",  "label": "Cholesterol absorption inhibitor (ezetimibe)" },
          { "id": "pcsk9", "label": "PCSK9 inhibitor" },
          { "id": "ace",   "label": "ACE inhibitor" },
          { "id": "ccb",   "label": "Calcium-channel blocker" }
        ],
        "correct": ["statin"],
        "explanation": "Atorvastatin is a statin."
      },
      {
        "id": "indications",
        "title": "Common indications",
        "prompt": "Select ALL common indications.",
        "type": "multi",
        "options": [
          { "id": "hyperlipid", "label": "Primary hypercholesterolaemia" },
          { "id": "fh",         "label": "Familial hypercholesterolaemia (adjunct)" },
          { "id": "prevention", "label": "CV risk reduction / secondary prevention" },
          { "id": "angina",     "label": "Stable angina treatment" },
          { "id": "pain",       "label": "Analgesia" }
        ],
        "correct": ["hyperlipid", "fh", "prevention"],
        "explanation": "Lipid lowering (incl. familial forms); cardiovascular risk reduction."
      },
      {
        "id": "moa",
        "title": "Mechanism of action",
        "prompt": "Which statement best describes the mechanism?",
        "type": "single",
        "options": [
          { "id": "moa_true", "label": "Inhibits HMG-CoA reductase → ↓cholesterol synthesis; ↑LDL receptors" },
          { "id": "moa_upreg","label": "Upregulates hepatic LDL receptors increasing LDL clearance" },
          { "id": "moa_ace",  "label": "Inhibits ACE" },
          { "id": "moa_ccb",  "label": "Blocks L-type Ca²⁺ channels" }
        ],
        "correct": ["moa_true"],
        "explanation": "Primary action is HMG-CoA reductase inhibition; LDL-receptor upregulation follows."
      },
      {
        "id": "adrs",
        "title": "Important adverse reactions",
        "prompt": "Select ALL clinically important ADRs.",
        "type": "multi",
        "options": [
          { "id": "myopathy", "label": "Myalgia/myopathy (rare rhabdomyolysis)" },
          { "id": "lfts",     "label": "↑Transaminases/hepatotoxicity" },
          { "id": "gi",       "label": "GI upset" },
          { "id": "dm",       "label": "Small increase in diabetes risk" },
          { "id": "cough",    "label": "Dry cough" }
        ],
        "correct": ["myopathy", "lfts", "gi", "dm"],
        "explanation": "Muscle symptoms, LFT elevation, GI upset; slight ↑ risk of new-onset diabetes."
      },
      {
        "id": "interactions",
        "title": "Important drug–drug interactions",
        "prompt": "Select ALL interactions of concern.",
        "type": "multi",
        "options": [
          { "id": "cyp3a4",   "label": "Strong CYP3A4 inhibitors (e.g., clarithromycin, azoles, protease inhibitors)" },
          { "id": "gfj",      "label": "Grapefruit juice (large amounts)" },
          { "id": "fibrates", "label": "Fibrates (e.g., gemfibrozil)" },
          { "id": "warfarin", "label": "Warfarin" }
        ],
        "correct": ["cyp3a4", "gfj", "fibrates"],
        "explanation": "CYP3A4 inhibitors & grapefruit raise statin levels; fibrates add myopathy risk."
      }
    ]
  }
]
